165 related articles for article (PubMed ID: 4270059)
21. [Analysis of the effects of chinoform on subacute myelo-optico-neuropathy (SMON)--application of linear regression analysis by logistic transformation].
Inoue N; Kuroiwa Y; Ikeda M; Yasukouchi T
Rinsho Shinkeigaku; 1974 Oct; 14(10):769-73. PubMed ID: 4282713
[No Abstract] [Full Text] [Related]
22. Is there SMON in India?
Wadia NH
Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127
[No Abstract] [Full Text] [Related]
23. Letter: S.M.O.N. and inflammation of the colon.
Shookhoff HB; Katz M
Lancet; 1973 Nov; 2(7837):1091. PubMed ID: 4127351
[No Abstract] [Full Text] [Related]
24. [Neurological complications in the course of treatment of acrodermatitis enteropathica with oxyquinoline derivatives].
Papuziński M; Wilmowska-Pietruszyńska A
Pediatr Pol; 1974 Nov; 49(11):1393-7. PubMed ID: 4278959
[No Abstract] [Full Text] [Related]
25. [Neurotoxic symptoms following clioquinol (Enterovioform)].
Pannekoek JH
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1611-5. PubMed ID: 4262824
[No Abstract] [Full Text] [Related]
26. [Polyneuropathy following long-term use of clioquinol (Enterovioform)].
van Beeck JA; Scholten JB
Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1621-2. PubMed ID: 4262827
[No Abstract] [Full Text] [Related]
27. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols.
Selby G
Proc Aust Assoc Neurol; 1973; 9():23-30. PubMed ID: 4268933
[No Abstract] [Full Text] [Related]
28. Relationship between neurological symptoms and concentrations of clioquinol in serum and nervous systems of beagle dogs.
Hayakawa K; Imanari T; Tamura Z; Kuroda S; Ikeda H; Tateishi J
Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):2013-8. PubMed ID: 144569
[No Abstract] [Full Text] [Related]
29. Neurotoxicity of clioquinol. 1. Oral administration of clioquinol to several species of animals.
Tateishi J; Kuroda S; Saito A; Otsuki S
Seishin Shinkeigaku Zasshi; 1972 Sep; 74(9):739-55. PubMed ID: 4630865
[No Abstract] [Full Text] [Related]
30. Data on clioquinol and S.M.O.N.
Lee JA
Lancet; 1978 Sep; 2(8092 Pt 1):738. PubMed ID: 80663
[No Abstract] [Full Text] [Related]
31. Data on clioquinol and S.M.O.N.
Shigematsu I; Yanagawa H
Lancet; 1978 Oct; 2(8096):945. PubMed ID: 81960
[No Abstract] [Full Text] [Related]
32. [Letter: Subacute myelopathy following hydroxyquinoleine absorption].
Laterre EC; Stevens A; Goffin L; Velghe L
Nouv Presse Med; 1973 Oct; 2(38):2550. PubMed ID: 4763459
[No Abstract] [Full Text] [Related]
33. Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-.
Shigematsu I
Jpn J Med Sci Biol; 1975; 28 Suppl():35-55. PubMed ID: 136540
[No Abstract] [Full Text] [Related]
34. Assessment of neurotoxicity of clioquinol (Enterovioform) by visual evoked potentials. A preliminary communication.
Bhasin DK; Raina R; Mehta SK; Arora MM
Indian J Gastroenterol; 1985 Jul; 4(3):165-6. PubMed ID: 3160659
[No Abstract] [Full Text] [Related]
35. Clioquinol and S.M.O.N.: Reanalysis of original data.
Asao M
Lancet; 1979 Feb; 1(8113):446. PubMed ID: 84300
[No Abstract] [Full Text] [Related]
36. [Abdominal symptoms of subacute myelo-optico-neuropathy (SMON)--with special reference to relationship between chinoform and ileus-like symptoms].
Inoue N; Tamura K; Kuroiwa Y; Ysukochi T; Naritomi T
Rinsho Shinkeigaku; 1973 Sep; 13(9):537-42. PubMed ID: 4796521
[No Abstract] [Full Text] [Related]
37. Going abroad.
Roe WP
Br Med J; 1972 Jun; 2(5816):770. PubMed ID: 4260938
[No Abstract] [Full Text] [Related]
38. Halogenated oxyquinoline derivatives and neurological syndromes.
Shimada Y; Tsuji T; Igata A; Steinitz H
Lancet; 1971 Jul; 2(7714):41-3. PubMed ID: 4103679
[No Abstract] [Full Text] [Related]
39. [Neurotoxicity of chinoform].
Iwashita H
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):602-5. PubMed ID: 10434730
[No Abstract] [Full Text] [Related]
40. [SMON and chinoform].
Tamura Z
Tanpakushitsu Kakusan Koso; 1973 Mar; 18(3):210-4. PubMed ID: 4197094
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
